Sphingolipids and neuronal degeneration in lysosomal storage disorders.


Journal

Journal of neurochemistry
ISSN: 1471-4159
Titre abrégé: J Neurochem
Pays: England
ID NLM: 2985190R

Informations de publication

Date de publication:
03 2019
Historique:
received: 03 05 2018
revised: 25 06 2018
accepted: 27 06 2018
pubmed: 1 7 2018
medline: 29 10 2019
entrez: 1 7 2018
Statut: ppublish

Résumé

Ceramide, sphingomyelin, and glycosphingolipids (both neutral and acidic) are characterized by the presence in the lipid moiety of an aliphatic base known as sphingosine. Altogether, they are called sphingolipids and are particularly abundant in neuronal plasma membranes, where, via interactions with the other membrane lipids and membrane proteins, they play a specific role in modulating the cell signaling processes. The metabolic pathways determining the plasma membrane sphingolipid composition are thus the key point for functional changes of the cell properties. Unnatural changes of the neuronal properties are observed in sphingolipidoses, lysosomal storage diseases occurring when a lysosomal sphingolipid hydrolase is not working, leading to the accumulation of the substrate and to its distribution to all the cell membranes interacting with lysosomes. Moreover, secondary accumulation of sphingolipids is a common trait of other lysosomal storage diseases. This article is part of the Special Issue "Lysosomal Storage Disorders".

Identifiants

pubmed: 29959861
doi: 10.1111/jnc.14540
doi:

Substances chimiques

Sphingolipids 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

600-611

Informations de copyright

© 2018 International Society for Neurochemistry.

Auteurs

Sara Grassi (S)

Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.

Elena Chiricozzi (E)

Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.

Laura Mauri (L)

Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.

Sandro Sonnino (S)

Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.

Alessandro Prinetti (A)

Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH